You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 The predicted cure rate and the actual cure rate for CDI patients in the validation database (all mITT patients in the 004 clinical trial with available values for all analyzed variables; n=452)

From: Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy

ATLAS score (nT) Predicted cure rate* (%) (nc §/nT) Actual cure rate (%) (nc/nT) Kappa P value
0 (69) 100 (69/69) 95.7 (66/69) N/A N/A
1 (89) 94.9 (84/89) 93.3 (83/89) 90.3% < 0.0001
2 (68) 89.8 (61/68) 92.7 (63/68) 81.8% < 0.0001
3 (86) 84.8 (73/86) 89.5 (77/86) 79.3% < 0.0001
4 (53) 79.7 (42/53) 81.1 (43/53) 94.1% < 0.0001
5 (46) 74.6 (34/46) 76.1 (35/46) 94.2% < 0.0001
6 (21) 69.5 (15/21) 85.7 (18/21) 58.8% 0.0031
7 (8) 64.4 (5/8) 50 (4/8) 75.0% 0.0285
8 (9) 59.4 (5/9) 55.6 (5/9) 100% 0.0027
9 (3) 54.3 (2/3) 33 (1/3) 40.0% 0.3865
10 (0) 49.2 (N/A) N/A N/A N/A
All scores (452) 86.3 (390/452) 87.4 (395/452) 95.2% < 0.0001
  1. CDI patients categorized by the ATLAS scoring system, using the regression formula* derived from the ATLAS system applied to the 003 clinical trial. Testing the reliability of the predicted cure rate compared to the actual cure rate among individual ATLAS groups and for the entire population was done using Kappa statistics.
  2. * Predicted cure rate = 100–5.08 x (ATLAS score).
  3. nc : number of subjects cured in the category.
  4. nT : total number of subjects in the category.
  5. §nc values for the predicted column were rounded to the nearest whole number.
  6. N/A: not applicable NS: not significant.